News Focus

Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)

Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Are we "HALTED" pending proper distribution of NEWS?

<< Previous

Bullboard Posts

Next >>

Comment by oilandgasmanon Feb 18, 2022 11:37am

138 Views

Post# 34442044

RE:Are we "HALTED" pending proper distribution of NEWS?

EDTXF

Spectral Medical Inc.

Ordinary Shares

0.28

-0.0166

-5.60%

0.28 / 0.2902 (1 x 1)

Real-Time Best Bid & Ask: 11:20am 02/18/2022

Delayed (15 Min) Trade Data: 11:09am 02/18/2022

Overview

Quote

Company Profile

Security Details

News

Financials

Disclosure

Research

OPEN

0.28152

DAILY RANGE

0.28 - 0.28152

VOLUME

11,300

DIVIDEND

N/A

REAL-TIME LEVEL 2 QUOTE

MPID	BID PRICE	TIME
ETRF	24.90	>year
CDEL	21.92	03/16
MACM	18.95	>year
NITE	18.95	>year
CSTI	18.55	>year

MPID	ASK PRICE	TIME
INTL	19.40	>year
NITE	19.40	>year
MACM	19.43	>year
MAXM	20.11	>year
CANT	22.05	>year

Unlock Real-Time quotes For EDTXFFIND OUT MORE

TRADE DATA

DATE	TIMESTAMP	PRICE	$ CHANGE	VOLUME
02/18/2022	11:20:34	0.28	0.00	4,500
02/18/2022	11:20:25	0.28	-0.00	2,500
02/18/2022	11:09:27	0.28152	-0.02	4,300
02/17/2022	12:31:09	0.2966	0.00	2,500
02/17/2022	12:31:08	0.29645	-0.00	500

MORE Irregular/odd lot trades, which are not considered for the Open, High, Low or Closing prices, are not shown in trade data table.

NEWS

Spectral Voluntarily Delists From OTCQXMKTW | 12/14/2016

Spectral Announces Appointment of Dr. Masayuki Kaneko to Its Board of DirectorsMKTW | 12/05/2016

Spectral Announces Next Steps in Path Forward and Issues Third Quarter ResultsMKTW | 11/11/2016

MORE

FILINGS AND DISCLOSURE

Supplemental Information - CFO CERTIFICATION OF INTERIM FILINGS11/11/2016

Supplemental Information - CEO Certificate CERTIFICATION OF INTERIM FILINGS11/11/2016

Interim Financial Report - Condensed Interim Consolidated Financial Statements11/11/2016

MORE

COMPANY DESCRIPTION

Spectral is a Phase III company seeking U.S. FDA approval for its lead theranostics product for the treatment of septic shock. Toraymyxin is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. Directed by the Company's Endotoxin Activity Assay (EAA), the only FDA-cleared diagnostic for the risk of developing sepsis, Spectral's EUPHRATES trial is the world's first theranostics trial in the area of sepsis.

VIDEOS

This company has not added any videos